Liver-specific AMPK knockout exaggerates NASH liver damage, whereas AMPK activation could protect against liver damage and fibrosis due to NASH by inhibiting caspases and CHOP (Dai et al., 2016; Zhao et al., 2020). This evidence concerns the gene DDIT3 and metabolic dysfunction-associated steatohepatitis.